Literature DB >> 21729795

Physican-directed (off-label) use of recombinant bone morphogenic protein-2: let us do it well!

Charles L Branch.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21729795     DOI： 10.1016/j.spinee.2011.04.005

Source DB:  PubMed          Journal:  Spine J        ISSN： 1529-9430            Impact factor:   4.166


× No keyword cloud information.
  2 in total

1.  Sub-clinical dose of bone morphogenetic protein-2 does not precipitate rampant, sustained inflammatory response in bone wound healing.

Authors:  Zachary J Grey; R Nicole Howie; Emily L Durham; Sarah Rose Hall; Kristi L Helke; Martin B Steed; Amanda C LaRue; Robin C Muise-Helmericks; James J Cray
Journal:  Wound Repair Regen       Date:  2019-03-09       Impact factor: 3.617

2.  Soft Tissue Swelling Associated with the Use of Recombinant Human Bone Morphogenetic Protein-2 in Long Bone Non-unions.

Authors:  Andrew Young; Adam Mirarchi
Journal:  J Orthop Case Rep       Date:  2015 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.